Further Evidence of CAR-T Efficacy in Relapsed or Refractory Multiple Myeloma

Abstract

Studies of chimeric antigen receptor T-cell (CAR-T) therapies have shown activity in relapsed/refractory multiple myeloma (R/R MM). In the latest